Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • nimmi
    Member
    • Jul 2010
    • 15

    scripture output

    We did RNA-seq on 5 cases and 5 controls. Following the documentation given on scripture website I got some results for Chr1. Below are few lines from the output. There are a total of 64K rows for Chr1, of which ~62K have FWER<0.05 and last column (Poisson pvalue) is significant for all the rows. Why are so many transcripts significant? Did anyone else observe this trend in their data?

    chrom chromStart chromEnd name score strand thickStart thickEnd itemRgb blockCount blockSizes blockStarts Family wise error rate (FWER) at the observed score Read enrichment (average reads per base over transcript / genome average) Total reads aligned transcript Average reads per base over transcript RPKM Genome average reads per base Transcript length Poisson nominal p-value for the observed count given the genome-wide average
    chr1 569913 570307 chr1:569913-570307 40848.5882 + 569913 570307 0,0,0 6 1,2,1,7,4,53, 0,3,7,9,17,341, 1.11E-16 10181.53598 109494 1610.205882 40848.5882 0.158149604 68 0
    chr1 16266622 16302620 chr1:16266622-16302620 68.37972491 - 16266622 16302620 0,0,0 15 2125,111,210,131,117,88,301,143,613,192,141,189,203,87,143, 0,2203,2401,2936,3471,3680,4172,4569,4809,5521,6026,6807,8167,32911,35855, 1.11E-16 17.0436889 12922 2.695452649 68.37972491 0.158149604 4794 0
    chr1 16266622 16302620 chr1:16266622-16302620 68.36914145 - 16266622 16302620 0,0,0 15 2125,111,210,131,122,83,301,143,613,192,141,189,203,87,143, 0,2203,2401,2936,3471,3685,4172,4569,4809,5521,6026,6807,8167,32911,35855, 1.11E-16 17.04105096 12920 2.695035461 68.36914145 0.158149604 4794 0

    thanks in advance,
    Nirmala

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
217 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
81 views
0 reactions
Last Post SEQadmin2  
Working...